1-8 of 8
Christophe Massard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Incidence of TP53 and Epigenetic Modifying Oncogenes Mutations in a Large Cohort of Patients Enrolled in Phase 1 Clinical Trials for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Cyril Quivoron, PhD, Jean-Marie Michot, MD, Valérie Camara-clayette, PhD, Alina Danu, MD, Julien Lazarovici, MD, Clementine Sarkozy, MD PhD, David Ghez, MD PhD, Julien Rossignol, MD PhD, Capucine Baldini, MD, Patricia Martin-Romano, MD PhD, Helene Lecourt, Veronique Vergé, MD, Andrea Varga, MD, Sophie Cotteret, MD PhD, Peggy Dartigues-Cuillères, MD, Christophe Massard, MD PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-136114
Published: 2020
Journal Articles

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort

Khe Hoang-Xuan, MDPhD, Roch Houot, MDPhD, Carole Soussain, MD PhD, Marie Blonski, MD, Anna Schmitt, MD, Vincent Delwail, MD, Gandhi Laurent Damaj, MD PhD, Herve Ghesquieres, MD PhD, Frédéric Peyrade, MD, Adrian Tempescul, MD, Julie Abraham, MD, Philippe Agape, MD, Guido Ahle, MD, Nathalie Baize, MD, Pierre Bories, MD, Chantal Campello, MD, Emmanuel Gyan, MD PhD, Fabrice Jardin, MD PhD, Philippe Rey, MD, Sylvain Choquet, MD, Caroline Houillier, MD, Nathalie Cassoux, MDPhD, Valerie Touitou, MDPhD, Nadine Martin-Duverneuil, MD, Frederic Legrand, Assia Lamrani-Ghaouti, Ophelie Querel, Natalie Hoog Labouret, MD, Clotilde Simon, Sylvie Chevret, MDPhD, Christophe Massard, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-141773
Published: 2020
Journal Articles

Is Molecular Characterization Useful for Targeted Therapy Orientation in Patients with Relapsed or Refractory DLBCL Included in Early Phase Clinical Trials?

Jean-Marie Michot, MD, Valérie Camara-Clayette, PhD, Cyril Quivoron, PhD, Alina Danu, MD, Julien Lazarovici, MD, David Ghez, MD PhD, Julien Rossignol, MD PhD, Capucine Baldini, MD, Patricia Martin-Romano, MD PhD, Clementine Sarkozy, MD PhD, Andrea Varga, MD, Helene Lecourt, Veronique Vergé, MD, Sophie Cotteret, MD PhD, Peggy Dartigues-Cuillères, MD, Christophe Massard, MD PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136134
Published: 2020
Journal Articles

Comparative Study of Tumor Biopsy and Ctdna to Support Patient Selection in Phase I Trials: The Gustave Roussy Single Center Experience in Aggressive B-Cell Lymphomas

Anthony Tarabay, MD, Jean-Marie Michot, MD, Anne Aupérin, Julien Lazarovici, Julien Rossignol, MD PhD, David Ghez, MD PhD, Peggy Dartigues-Cuillères, MD, Veronique Vergé, Vincent Ribrag, MD, Christophe Massard, Valérie Camara-clayette
Journal: Blood
Blood (2019) 134 (Supplement_1): 1496.
https://doi.org/10.1182/blood-2019-127170
Published: 2019
Journal Articles

Feasibility and Benefit of Molecularly-Informed Enrollment into Early Phase Clinical Trials for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jean-Marie Michot, MD, Valérie Camara-clayette, Audrey Detolle, Claude Chahine, MD, Julien Lazarovici, MD, Alina Danu, MD, Jacques Bosq, David Ghez, MD PhD, Peggy Dartigues-Cuillères, MD, Julia Arfi-Rouche, Rastilav Bahleda, Wassila Rahali, Andrea Varga, Capucine Baldini, Lambros Tselikas, Clélia Paume, Helene Lecourt, Sophie Cotteret, Veronique Vergé, Jean-Charles Soria, Christophe Massard, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4110.
https://doi.org/10.1182/blood-2018-99-110852
Published: 2018
Journal Articles

Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies

Jean-Marie Michot, MD, Nicolas Delanoy, Thibault Comont, Nora Kramkimel, Romain Dupont, Julien Lazarovici, MD, Stéphane Champiat, Caroline Robert, Charles Herbaux, MD, Benjamin Besse, Claude Chahine, MD, Aude Guillemin, Christine Mateus, Patricia Pautier, Philippe Saiag, Emmanuela Madonna, Marie Maerevoet, MD, Jean-Christophe Bout, Charlotte Leduc, Pascal Biscay, Gilles Quere, Christophe Nardin, Mikael Ebbo, Laurence Albiges, Grégoire Marret, Virginie Levrat, Cécile Dujon, Salim Laghouati, Laure Croisille, MD PhD, Anne-Laure Voisin, Bertrand Godeau, MD, Christophe Massard, Vincent Ribrag, MD, Aurelien Marabelle, MD PhD, Marc Michel, Olivier Lambotte
Journal: Blood
Blood (2018) 132 (Supplement 1): 2412.
https://doi.org/10.1182/blood-2018-99-110875
Published: 2018
Journal Articles

Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials

Marion Brault, Maxime Annereau, PharmD, Alina Danu, MD, Julien Lazarovici, MD, Claude Chahine, MD, Andrea Varga, Capucine Baldini, Stéphane Champiat, Malik Berhoune, Christophe Massard, François Lemare, Vincent Ribrag, MD, Jean-Marie Michot, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2992.
https://doi.org/10.1182/blood-2018-99-112919
Published: 2018
Journal Articles

Feasibility and Benefit of Molecularly-Informed Enrollment into Personalized Therapies or Early Phase Trials for Patients with Relapsed or Refractory Multiple Myeloma

Tarek Assi, Jean-Marie Michot, MD, Toni Ibrahim, MD MSc, Fabien Le Bras, Karim Belhadj, Julien Lazarovici, MD, David Ghez, MD PhD, Julien Rossignol, MD PhD, Veronique Vergé, Julia Arfi-Rouche, Sophie Cotteret, Christophe Massard, Jean-Charles Soria, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2001.
https://doi.org/10.1182/blood-2018-99-111050
Published: 2018